BioWorld MedTech

Jan. 28, 2013

InTouch gains clearance for RP-VITA for use in hospitals

A partnership between two companies has led to the development of an autonomous robotic system, which could have the potential to significantly make the jobs of physicians and clinicians a bit easier. Read More

Cytox raises $5.5M to continue Alzheimer's test development

International report: Varian selected to equip cancer center in Algeria

Washington roundup: Device contractors in limbo in new combo product final rule

Financings roundup: LipoScience reports pricing of initial public offering

Grants roundup: Arsenal Medical will provide injectable foam to military

Court report: HCA must pay $162M to Kansas City area community foundation

Agreements/contracts: Tenet's San Ramon Regional joins with John Muir Health

Med-Tech Notes

People in the News

Product Briefs

MDD's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for April 15, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 15, 2025.

Caution tape displaying US flag, tariffs

Biopharma exempt from US reciprocal tariffs, but not untouched

BioWorld

At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...

Antibodies binding to spike proteins on the surface of SARS-CoV-2 virus

Australian researchers discover new compound to treat long COVID

BioWorld

Researchers have developed a new compound that can prevent long COVID symptoms in mice that could lead to a future drug for the debilitating condition in humans....

Blood glucose chart and monitor, stethoscope, injector pen

Hightide’s HTD-1801 meets phase III endpoints in type 2 diabetes

BioWorld

Hightide Therapeutics Inc.’s berberine ursodeoxycholate (HTD-1801) met primary and secondary endpoints in the Symphony 1 and Symphony 2 phase III trials in type 2...